Landos Biopharma, Inc. EBITDA 2021-2024 | LABP
Landos Biopharma, Inc. ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Landos Biopharma, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-23 |
| 2022 | $-39 |
| 2021 | $-37 |
| 2020 | $-31 |
| 2019 | $-13 |
| Landos Biopharma, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-9 |
| 2023-12-31 | $-7 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $-6 |
| 2022-09-30 | $-7 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-14 |
| 2021-12-31 | $-20 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $4 |
| 2021-03-31 | $-10 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-5 |
| 2020-03-31 | $-6 |
